Bruno Paiva
@BrunoPaiva_UNAV
Husband and father of 4! 🥋 Director Flow Cytometry Core - CIMA LAB Diagnostics Director Myeloma Laboratory - Clinica & CIMA Universidad de Navarra
Queremos eliminar el significado incierto de las gammapatías monoclonales, y para ello estudiaremos a 5,000 pacientes en España. Os invitamos a participar en @NO_MORE_MGUS (nomoremegus.com) y hacer de este sueño una realidad. @Cemmp_mieloma @criscancer @_pethema
#EHA2025 survey by EMA in collaboration with @Myeloma_Society about attitudes of HCP and regulators towards MRD endpoint in myeloma #mmsm Varied opinions, but agreement that treatments with MRDneg increase of >20%, and toxicity increase from 40% to max 60%, were clinically useful
#EHA2025 lifetime achievement award to Jesús San Miguel: "Happiness is not doing what you want but wanting what you do" JSM quotes the words of JP Sartre and shares his treasures with the audience: the big families he built at home, @HematoCAUSA @ClinicaNavarra @_pethema #mmsm
#EHA2025 lifetime achievement award to Jesús San Miguel; my boss, mentor, friend, wedding planner and second-father! 18 years ago I was blessed by start working under his leadership, and I'm looking forward to the next 18 years! #mmsm @ClinicaNavarra @CIMA_unav @sehh_es @_pethema
📢 ¡El webinar #PostASCO & #PostEHA 2025 de @SanofiES es este jueves 26! Descubre las novedades en el abordaje integral del mieloma múltiple 🗓️26 de junio ⏰16:30 – 18:30 Registro👉webapp.spotme.com/login/sanofi17… Contenido para profesional sanitario
📢 O webinar @SanofiES #PostASCO e #PostEHA 2025 é esta quinta-feira dia 26! Descubra os últimos desenvolvimentos na abordagem completa do mieloma múltiplo 🗓️26 de junho ⏰16:30 – 18:30 Registo👉webapp.spotme.com/login/sanofi17… Conteúdo para profissionais de saúde
📢¡Este jueves 26 es el webinar #PostASCO & #PostEHA 2025 de @SanofiES! Ponte al día en mieloma múltiple revisando lo más importante visto en ASCO y EHA 🗓️26 de junio ⏰16:30 – 18:30 Registro👉webapp.spotme.com/login/sanofi17… Contenido para profesional sanitario
📢 O webinar #PostASCO&#PostEHA 2025 da @SanofiES é esta quinta-feira dia 26! Atualize-se sobre o mieloma múltiplo revendo as coisas mais importantes apresentadas no ASCO e EHA. 🗓️26 de junho ⏰16:30 – 18:30 Registo👉webapp.spotme.com/login/sanofi17… Conteúdo para profissionais de saúde
Major Regulatory Milestone in MM: In response to an application by I2TEAMM and @IMFmyeloma, the European Medicines Agency has officially endorsed MRD as an early endpoint in clinical trials for Myeloma. This marks a transformative step forward in drug development !! @VincentRK
📢SAVE THE DATE O Webinar @SanofiES #PostASCO e #PostEHA 2025 está aqui! Poderá ver um resume dos resultados mais relevantes no mieloma múltiplo apresentados no ASCO e EHA 🗓️26 de junho ⏰16:30 – 18:30 Registo👉 webapp.spotme.com/login/sanofi17… Conteúdo para profissionais de saúde
📢SAVE THE DATE ¡El Webinar #PostASCO & #PostEHA 2025 de @SanofiES está aquí! Podrás conocer las novedades presentadas en ASCO y EHA de mieloma múltiple 🗓️26 de junio ⏰16:30 – 18:30 Registro👉 webapp.spotme.com/login/sanofi17… Contenido para profesional sanitario
📢SAVE THE DATE Próximos #PostASCO Webinar #PostEHA 2025 @SanofiES Quer saber o que há de novo no mieloma múltiplo apresentado no ASCO e EHA? Conecte-se! 🗓️26 de junho ⏰16:30–18:30 Registo👉webapp.spotme.com/login/sanofi17… Conteúdo para profissionais de saúde
📢SAVE THE DATE Próximo Webinar #PostASCO & #PostEHA 2025 de @SanofiES ¿Quieres conocer las novedades de ASCO y EHA en mieloma múltiple? ¡Conéctate! 🗓️26 de junio ⏰16:30–18:30 Registro👉webapp.spotme.com/login/sanofi17… Contenido para profesional sanitario
My advance congratulations to Dr. Jesus San Miguel who will receive the @EHA_Hematology Lifetime Achievement Award Tomorrow at #EHA25 Dr. SanMiguel has made incredible contributions to the field. A close friend and mentor to me. I’m sorry to miss the ceremony.
CONGRESS | #EHA2025 | @LucaBertamini @ErasmusMC presents results from a pooled analysis of prospective data, assessing the independent prognostic value of CTCs in newly diagnosed #MultipleMyeloma and plasma cell leukemia (N = 2446). Results support the assessment of CTC as a…
#EHA2025 CTC session in myeloma and amyloidosis #mmsm CTCs are fighting for a sit on the table of routine staging of these patients. Congrats Ioannis Kostopoulos, @juanjogrcs @LucaBertamini @DZihala @TomasJelinekMD @Dagostino_MD
#EHA2025 had @Carmen_gondc presenting the phenotype and genetic landscape of clonotypic cells in myeloma and amyloidosis #mmsm These cells may be immature, carry some mutations but not drivers of progression. May explain some discordances between NGF/NGS MRD results. @CIMA_unav
Our lab fantastic postdoc @juanjogrcs will present today our study on CTC in multiple myeloma @mmsm. Several relevant findings by linking WGS, RNAseq and CTC. Great collaboration with @TomasJelinekMD @BenDiamondMD @szusmani @MSKCancerCenter @OsuChsd @univmiami @theMMRF #mmsm
Almost ready to present our work about #CTCs at #EHA2025, come to learn about how #liquidbiopsies can change the paradigm of #mmsm!
Amazing!!! #EHA2025 @ClinicaNavarra @CimalabUnav @CIMA_unav @unav #EHA2025 lifetime achievement award to Jesús San Miguel
👍Enhorabuena, muy merecido siempre, los #pacientes de #mieloma estamos con el @Cemmp_mieloma
#EHA2025 lifetime achievement award to Jesús San Miguel; my boss, mentor, friend, wedding planner and second-father! 18 years ago I was blessed by start working under his leadership, and I'm looking forward to the next 18 years! #mmsm @ClinicaNavarra @CIMA_unav @sehh_es @_pethema
Very proud of seeing Dr San-Miguel receiving this prestigious award at #EHA2025 . Well deserved by his scientific contributions and, I'd dare to say, by his close and extremely valuable supervision!
#EHA2025 lifetime achievement award to Dr. Jesús San Miguel. Congratulationsssssssss @ClinicaNavarra @CIMA_unav @sehh_es @_pethema @CimalabUnav